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Coordination of differentiation and cell cycle progression represents an essential process for embryonic development
and adult tissue homeostasis. These mechanisms ultimately determine the quantities of specific cell types that are
generated. Despite their importance, the precise molecular interplays between cell cycle machinery and master
regulators of cell fate choice remain to be fully uncovered. Here, we demonstrate that cell cycle regulators Cyclin
D1–3 control cell fate decisions in human pluripotent stem cells by recruiting transcriptional corepressors and
coactivator complexes onto neuroectoderm, mesoderm, and endoderm genes. This activity results in blocking the
core transcriptional network necessary for endoderm specification while promoting neuroectoderm factors. The
genomic location of CyclinDs is determined by their interactionswith the transcription factors SP1 and E2Fs, which
result in the assembly of cell cycle-controlled transcriptional complexes. These results reveal how the cell cycle
orchestrates transcriptional networks and epigenetic modifiers to instruct cell fate decisions.
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Embryonic development, organogenesis, and tissue repair
are controlled through the proliferation and differentia-
tion of stem cells and progenitors. The importance of
these mechanisms has been demonstrated in adult stem
cells (Oshimori and Fuchs 2012) and also in pluripotent
stem cells (Sela et al. 2012; Calder et al. 2013; Coronado
et al. 2013; Singh et al. 2013, 2015). Human embryonic
stem cells (hESCs) represent an advantageous model sys-
tem for investigating the cross-talk between cell cycle
and cell fate choice. hESCs can proliferate indefinitely
while maintaining the capacity to differentiate into the
three primary germ layers neuroectoderm, mesoderm,
and endoderm in vitro. Furthermore, hESCs are character-
ized by a specific cell cycle profile with a short G1 phase,
while their differentiation is associated with an increase
in G1 phase length (Coronado et al. 2013). A recent study
has shown that Cyclin D1–3/CDK4/6 complexes, which
control G1 length and progression, also limit the tran-
scriptional activity associated with Activin/Nodal signal-
ing during the late G1 phase. This mechanism results in a
cell cycle-dependent capacity of differentiation in which
hESCs can only differentiate into endoderm in their early
G1 phase and into neuroectoderm in their late G1 (Pau-
klin and Vallier 2013). Finally, S- andG2/M-relatedmech-
anisms appear to control the inhibition of pluripotency
upon differentiation, suggesting the existence of differen-
tiation checkpoints during cell cycle progression in stem
cells (Gonzales et al. 2015). These reports collectively
demonstrate that cell cycle regulators have a direct func-
tion in early events of differentiation by controlling the
activity of extracellular signals. Interestingly, cell cycle
regulators are also known to function at the chromatin
level and control gene transcription (Sicinski et al. 2007;
Pestell 2013). For instance, Cyclin D proteins have been
found on DNA in mouse cancer cell lines but also in
mouse retinal tissue (Bienvenu et al. 2010; Casimiro
et al. 2012). However, the function of Cyclin D-mediated
transcriptional mechanisms has never been studied in the
context of stem cells and cell fate choice.
Here we demonstrate that the cell cycle machinery is
directly involved in the transcriptional initiation of de-
velopmental genes controlling primary germ layer spec-
ification. Cyclin D1, which is highly expressed in late
G1, recruits transcriptional corepressors to endoderm
genes and coactivators to neuroectoderm genes, thereby
blocking or promoting the induction of the correspond-
ing germ layers. Thus, Cyclin D1 acts as a cell cycle-
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dependent transcriptional regulator, which can direct lin-
eage specification of stem cells. These results show how
cell cycle regulators can orchestrate cell fate decisions by
organising transcriptional networks in human stem cells.
Results
Cyclin D1 promotes neuroectoderm differentiation
through chromatin-binding-dependent mechanisms
that do not involve inhibition of Smad2/3 by CDK4/6
phosphorylation
We recently showed that hESC differentiation is regulated
by the cell cycle through mechanisms involving con-
trol of the Activin/Nodal signaling pathway via Smad2/
3 phosphorylation byCyclin D–CDK4/6 (Pauklin andVal-
lier 2013). We also observed that constitutive expres-
sion of Cyclin D1 and, to a lesser extent, Cyclin D2 and
Cyclin D3 can rapidly increase the expression of neuronal
markers independently of Smad2/3 inhibition. These re-
sults suggested that Cyclin Ds might prime the hESCs to-
ward neuronal differentiation independently of Smad2/3–
CDK4/6 cross-talk. To explore this hypothesis further, we
decided to perform teratoma assays as an unbiased ap-
proach to evaluate pluripotency of hESCs overexpressing
GFP or Cyclin D1 (Fig. 1A–D). Histological analyses of
the resulting tumors were performed to define the propor-
tion of germ layer derivatives generated. These analyses
revealed that teratomas derived from control GFP-hESCs
contained similar proportions of derivatives from the
three germ layers, while Cyclin D1-hESC-derived terato-
mas contained 77% of neuroectodermal tissues (Fig. 1A–
D; Supplemental Fig. S1A–C). In addition, statistical anal-
yses showed that neuroectodermwas themain germ layer
affected by Cyclin D1 overexpression (X2 = 152.5, Bonfer-
roni corrected; P < 6.6 × 10−16, χ2 test). Thus, CyclinD1 ap-
pears to trigger differentiation of hESCs toward the
neuroectodermal lineage independently of the surround-
ing environment. Next, we investigated whether Cyclin
D1 could promote neuroectoderm specification in the ab-
sence of CDK4/6 activity by taking advantage of a highly
specific CDK inhibitor, PD0332991 (Supplemental Fig.
S1D; Fry et al. 2004). The addition of this small molecule
in culture medium and thus the absence of Smad2/3 inhi-
bition by CDK4/6 were not sufficient to block Cyclin D1
overexpression from inducing neuroectoderm and repress-
ing endoderm differentiation, and this was confirmed by
CDK4/6 knockdown (Fig. 1E; Supplemental Fig. S1E–H).
Similar effects were obtained by overexpressing in hESCs
a Cyclin D1 K112E mutant (CycD1-K112E) (Fig. 1F,G)
that does not bind and activate CDK4/6 (Supplemental
Fig. S1I; Baker et al. 2005). Considered together, these
findings confirm that Cyclin D1 can direct cell fate deci-
sions of hESCs independently of CDK4/6 activity.
Cyclin D1 inhibits endoderm differentiation through
a chromatin-binding-dependent mechanism in addition
to CDK4/6–Smad2/3 cross-talk
The above results suggest the existence of cell-autono-
mous mechanisms allowing Cyclin D1 to direct cell fate
choice. Interestingly, studies in mouse retinal tissue and
mouse cancer lines have shown that Cyclin D1 can par-
ticipate in transcriptional regulation (Yu et al. 2005;
Casimiro et al. 2012). However, whether this cell cycle
regulator could also have a similar role in pluripotency
exit and stem cell differentiation is unknown. Hence,
we decided to explore whether similar mechanisms could
occur in hESCs and could help to explain the CDK4/6-in-
dependent function of Cyclin D1 in neuroectoderm spec-
ification. For that, we performed Western blot analyses
to determine the subcellular localization of Cyclin D pro-
teins in hESCs and during their differentiation. These
analyses revealed that Cyclin D1–3 not only localize to
cytoplasm but also reside on chromatin in pluripotent
cells (Fig. 2A,B). Cyclin D1–3 could also be found on the
chromatin of neuroectodermal derivatives (Fig. 2C) and,
to a lesser extent, in endoderm/mesoderm cells (Fig. 2C;
Supplemental Fig. S2A,B). Together, these observations
suggest that Cyclin Ds could indeed have a function on
chromatin in hESCs.
To further uncover the mechanisms involving Cyclin
Ds in the nucleus, we decided to perform a series of func-
tional experiments focusing on Cyclin D1, since this is
the most abundant Cyclin D on the chromatin while hav-
ing the strongest effect on neuroectoderm differentiation
(Pauklin and Vallier 2013; data not shown). We first over-
expressed in hESCs a mutant form of Cyclin D1 (Cyclin
D1 T286A [CycD1-T286A]) that accumulates in the nu-
cleus due to the absence of phosphorylation of the residue
T286 (Fig. 2D,E; Alt et al. 2000). CycD1-T286A hESCs
showed a pronounced loss in pluripotency and meso-
derm/endoderm gene expression and an increased neuro-
ectoderm gene expression when compared with GFP or
wild-type Cyclin D1 hESCs (Fig. 2F,G; Supplemental
Figs. S2C–G, S3A–F). Furthermore, the effects of CycD1-
T286A were maintained even with CDK4/6 inhibition
(Supplemental Fig. S3G). Collectively, these results con-
firm that Cyclin D1 can influence cell fate decisions
through nuclear mechanisms independently of CDK4/6.
SinceCyclinD1 controls accumulation of Smad2/3 into
the cytoplasm during the late G1 phase of the cell cycle,
we decided to determine whether the nuclear function
of Cyclin D1 could be independent of the Activin/Nodal
signaling pathway (Pauklin and Vallier 2013). FUCCI
hESCs transitorily transfected with Flag-NLS-Smad2/3
(Lo and Massague 1999) could not overcome the inhibi-
tion of endoderm differentiation in late G1 (Fig. 2H), sug-
gesting that forced nuclear import of Smad2/3 is not
sufficient to bypass the mechanisms preventing this dif-
ferentiation. Furthermore, inhibition of CDK4/6 results
in only a limited increase in Sox17-expressing cells in en-
doderm differentiation induced in late G1, confirming
the existence of Smad2/3 phosphorylation-independent
mechanisms (Fig. 2H; Supplemental Fig. S3H–J). Finally,
CycD1-K112E was able to significantly reduce the activi-
ty of a constitutive form of Activin receptor, ActRIB
(ActRIB-T206A; P≤ 0.05) (Fig. 2I), without affecting the
binding of Smad2/3 to its target loci (Fig. 2J). Taken to-
gether, these data demonstrate that Cyclin D1 has a nu-
clear function in hESCs that promotes neuroectoderm
and blocks endoderm specification independently of
Pauklin et al.
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CDK4/6-mediated inhibition of Activin/Nodal–Smad2/3
signaling (Fig. 2K).
Genome-wide identification of Cyclin D1 target
genes regulating stem cell differentiation
The functional studies described above support the hy-
pothesis that Cyclin D1 functions via chromatin binding
for controlling cell fate choice in hESCs. Previous studies
on Flag-tagged Cyclin D1 in mice have shown that this
protein can regulate gene expression by interacting with
transcription factors and epigenetic modifiers in cancer
cells and mouse embryos (Fu et al. 2005a,b; Landis et al.
2006; Geng et al. 2007; Sicinski et al. 2007; Bienvenu
et al. 2010; Casimiro et al. 2012). Consequently, we hy-
pothesized that Cyclin D1’s role in the nucleus could be
Figure 1. Cyclin D proteins can regulate cell fate decisions in hESCs independently of CDK4/6 activity. (A) Schematic overview of ter-
atoma assay. (B) Histological sections of teratomas derived fromGFP-overexpressing hESCs. (K) Kidney; (ME) mesoderm; (EN) endoderm;
(NE) neuroectoderm. (C ) Ratio of histological structures specific to each germ layer.X2 = 152.5, Bonferroni correctedP < 6.6 × 10−16, χ2 test.
(D) Histological sections of teratomas derived fromCyclin D1 overexpressing hESCs. (E) CDK4/6 inhibition does not fully abolish Cyclin
D function. Significant differences calculated by two-wayANOVA aremarked. (F ) Morphology of a CycD1-K112Emutant overexpressing
hESCs. Representative colonies of hESCs overexpressing GFP and CycD1-K112E. (G) The CycD1-K112E mutant, which is not able to ac-
tivate CDK4/6, can block endoderm genes and induce neuroectoderm. Significant differences compared with overexpressing GFP and cal-
culated by t-test are marked. All data are shown as mean ± SD. n = 3.
Stem cell differentiation is regulated by Cyclin D
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Figure 2. Nuclear Cyclin D binds to developmental loci and induces neuroectodermwhile blocking endoderm differentiation in hESCs.
(A) Cyclin D is localized both in the cytoplasm and on chromatin in hESCs. Cytoplasm, nucleoplasm, and chromatin were isolated from
H9 cells and analyzed for CyclinD1–3 protein byWestern blot. Oct4 was used as a positive control. (B) Cyclin D knockdown in chromatin
fractions. Chromatin fractions isolated fromH9 cells expressing Scramble, Cyclin D1, Cyclin D2, or Cyclin D3 shRNAwere analyzed for
Cyclin Ds by Western blot. (C ) Cyclin D cellular location during differentiation. H9 hESCs were differentiated into neuroectoderm, en-
doderm, and mesoderm. Cytoplasm and chromatin fractions were isolated and analyzed for relative Cyclin D1–3 levels by Western blot.
Actin and Histone H3 acted as loading controls for cytoplasm and chromatin, respectively. (D) Morphology of hESCs overexpressing the
Cyclin D1 T286A (CycD1-T286A) mutant. Representative colonies of hESCs overexpressing GFP and CycD1-T286A. (E) The CycD1-
T286A mutant accumulates in the nucleus of hESCs. Western blot of Cyclin D1 in the cytoplasmic fraction and nucleoplasm. (F,G)
CycD1-T286A overexpression causes neuroectoderm differentiation. Expression of neuroectoderm markers in CycD1-T286A-overex-
pressing cells shown by Western blot (F ) and quantitative PCR (qPCR) (G). Significant differences compared with overexpressing GFP
and calculated by two-wayANOVA aremarked. (H) Nuclear Smad2 cannot bypass endoderm inhibition in late G1 cells. (Left panel) Sche-
matic overview of the experiment. Tra-1–60-positive Fucci hESCswere sorted into earlyG1, lateG1, and S/G2/Mphase and differentiated
into endoderm. (Right panel) Fucci hESCs transfectedwith Smad2 constructs 48 h before cell sortingwere selected for 12 hwith the goal of
removing nontransfected cells and then sorted into late G1 phase and analyzed for marker expression by flow cytometry 1 or 2 d after
endoderm differentiation. (I ) CycD1-K112E cells can block endoderm and induce neuroectoderm differentiation in the presence of con-
stitutively activated Activin–Smad2/3 signaling. Analysis of Sox17 expression by flow cytometry in cells transfected with ActRIB-ex-
pressing constructs. Significant differences calculated by t-test are marked. (J) CycD1-K112E regulates differentiation without affecting
Smad2/3 binding to its target loci. Smad2/3 chromatin immunoprecipitation (ChIP) was performed in cells expressing GFP, Cyclin D1,
or CycD1-K112E. Significant differences calculated by t-test are marked. (K ) Schematics of dual mechanistically distinct functions for
Cyclin D proteins in stem cell fate decisions. Cyclin Ds can repress endoderm in the cytoplasm by inhibiting Smad2/3 via CDK4/6 acti-
vation as shown before. Cyclin D proteins can also regulate cell fate decisions in stem cells in the nucleus that are independent of CDK4/6
and Smad2/3. All data are shown as mean ± SD. n = 3.
Pauklin et al.
424 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on April 1, 2018 - Published by genesdev.cshlp.orgDownloaded from 
to control transcription of genes that are involved in cell
fate decisions of hESCs.
To investigate this potential function, we performed
genome-wide identification of endogenous Cyclin D1-
binding sites in hESCs using chromatin immunoprecipi-
tation (ChIP) followed by high-throughput sequencing
(ChIP-seq). We identified 400 significantly read-enriched
genomic regions (or peaks) to be reproducible between
two independent biological replicates (P≤ 1 × 10−5; false
discovery rate [FDR] ≤0.01). Peaks were associated with
1519 target geneswithin regions spanning 50 kb upstream
of and 50 kb downstream from the Cyclin D1 peaks, and
about half of the genes are protein-coding (Fig. 3A; Supple-
mental Table S1). The majority of the peaks were overlap-
ping with or located close to transcription start sites
(Fig. 3B; Supplemental Tables S2, S3), and >30%of the Cy-
clin D1-binding sites in hESCs were located in proximal
promoter regions within 5 kb of genes (Fig. 3C). Interest-
ingly, Cyclin D1 also binds a large number of intergenic
regions >10 kb upstream of or downstream from genes,
which could represent enhancers and regulatory regions,
since a proportion of these overlap with H3K4me1 and
H3K27ac regions. Thus, Cyclin D1 could also control
gene expression via long-distance interactions of enhanc-
er–promoter regions. Together, these observations rein-
force our hypothesis concerning the involvement of
Cyclin D1 in transcriptional regulation of genes in hESCs.
To investigate the putative functional pathways of
the Cyclin D1 target genes, we performed gene ontology
(GO) analysis. GO terms associated with the 740 pro-
tein-coding geneswere significantly enriched for terms re-
lated to enzyme binding (P = 1.63 × 10−6) and chromosome
organization (P = 3.32 × 10−5) (Supplemental Table S4).
Representative Cyclin D1 target genes were chromosome
segregation factors such as AURKB and CENPM (Fig. 3D)
that have previously been identified as targets of Cyclin
D1 in mouse embryonic fibroblasts (Casimiro et al.
2012) and have been implicated in chromosome insta-
bility in cancers (Thompson et al. 2010; Casimiro and
Pestell 2012; Pestell 2013). Among the target genes were
also replication protein RPA1, cell cycle regulator
RGCC (Fig. 3D; Supplemental Table S4), and DNA topo-
isomerase TOP1. Importantly, the GO terms enriched
for Cyclin D1 target loci also included cell morphogenesis
(P = 1.1 × 10−5), anatomical development (P = 2.2 × 10−4),
cell differentiation (P = 5.63 × 10−4), and DNA binding
(P = 7.64 × 10−3) (Fig. 3E). These results suggest that Cyclin
D1 could act as a transcriptional regulator during cell fate
choice of stem cells.
Cyclin D1 binds to its developmental target loci
in a cell cycle-dependent manner
To further determine whether Cyclin D1 target genes
included regulators of cell fate decisions, we compared
their expression levels in endoderm, mesoderm, and neu-
roectoderm using published RNA sequencing (RNA-seq)
data (Fig. 3F; Gifford et al. 2013). We did not observe
an overall uniform change in expression of all Cyclin D1
target genes, suggesting that Cyclin D1 does not act as a
genome-wide repressor or activator of transcription (Sup-
plemental Fig. S4B). However, Cyclin D1 could act as a lo-
cus-specific regulator of developmental genes, as, among
its target loci, we found important inducers of germ layer
specification that showed up-regulation primarily in neu-
roectoderm (cluster 3:OTX1, LMO1, and TIAM1) (Fig. 3F;
Supplemental Table S5), endoderm (cluster 2: Wnt3,
Smad2, and VEGFA) (Fig. 3F), or mesoderm (cluster 1:
RARB, DKK1, and Smad6) (Fig. 3F) as well as genes that
indicate a down-regulation upon stem cell differentiation
to all three germ layers (cluster 4: Wnt6, GLI2, and
LIN28A) (Fig. 3F).
Since Cyclin D1 target genes included regulators of
germ layer specification such as transcription factors
and components of signaling pathways (Wnt, Bmp4, and
Activin/Nodal/TGFβ) (Pauklin and Vallier 2015), we de-
cided to focus on a subset of these genes that showed a
strong enrichment in Cyclin D1 binding in ChIP-seq anal-
ysis (Fig. 4A; Supplemental Fig. S4A–C). First, we con-
firmed the binding of Cyclin D1 to these genomic
regions (Fig. 4B; Supplemental Fig. S4D). Of note, we
also showed the absence CDK6 on the same genome re-
gions byChIP and quantitative PCR (ChIP-qPCR) (Supple-
mental Fig. S5A), thereby confirming that Cyclin D
control of transcription is independent of its phosphory-
lation activity. Furthermore, these developmental target
genes showed distinct expression patterns in hESCs dif-
ferentiated into three germ layers using defined culture
condition (Supplemental Fig. S5B,C). Importantly, the en-
doderm-specific genes were repressed by Cyclin D1 over-
expression, whereas the neuroectoderm-specific genes
were induced (Fig. 4C). Furthermore, Cyclin D1/Cyclin
D2 double knockdown resulted in opposite changes of ex-
pression for these genes when compared wth overexpres-
sion (Fig. 4C), suggesting that Cyclin D1 could control
stem cell fate choice by transcriptional induction of neu-
roectoderm genes (Pax2, Sox3, PBX1, DACH1, and Otx1)
and transcriptional repression of endoderm genes (Sox18,
Wnt3, and Smad2). Finally, we tested the binding of Cy-
clinD1 to its target loci in FUCCI hESCs sorted to distinct
cell cycle phases. Since Cyclin Ds are specifically ex-
pressed in late G1, we hypothesized that Cyclin D1would
bind those genomic regions in specific phases of the cell
cycle. Accordingly, ChIP-qPCR analyses demonstrated
that Cyclin D1 binds promoters of neuroectoderm (Fig.
4D) and endoderm (Fig. 4E) factors specifically during
the late G1 phase and G1/S transition. These data collec-
tively suggested that Cyclin D1 could control the tran-
scriptional activity of developmental genes by binding
proximal regulatory regions in a cell cycle-dependent
manner.
Cyclin D1 recruits transcriptional coregulators to control
the expression of developmental genes in stem cells
To understand themechanisms involved in Cyclin D1-de-
pendent transcriptional regulation, we analyzed the im-
pact of Cyclin D1 on the epigenetic landscape of its
target genes. The knockdown of Cyclin D1 resulted in
the loss of the histone modification H3K4me3 on
Stem cell differentiation is regulated by Cyclin D
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Figure 3. Genome-wide detection ofDNA-binding occupancy for endogenousCyclinD1 in hESCs. (A) The function of genes spanning 50
kb upstream of and 50 kb downstream fromCyclin D1-binding peaks. Classification of the genes close to Cyclin D1-binding regions iden-
tified by ChIP-seq. (B) The localization of Cyclin D-binding peaks. The distance of Cyclin D1 peaks relative to the transcription start site
(TSS) of surrounding genes. (C ) Peak annotation of Cyclin D-binding regions on its target genes. Promoter regions span 10 kb upstream of
the transcription start site, while immediate downstream regions span 5 kb after 3′ untranslated regions (UTRs). (D) Cyclin D1-binding
site close to the cell cycle regulator genes RGCC and RPA1 and chromosome segregation factors AURKB and CENPM, which are also
Cyclin D1 targets inmice. Genomic region 50 kb upstream of and 50 kb downstream from the binding peak. (E) Cyclin D1 targets include
developmental loci and genes involved in differentiation. Selected gene ontology terms of genes surrounding Cyclin D1-binding regions.
(F ) Euclidian k-means (k = 4) hierarchical clustering of RNA sequencing (RNA-seq) data in the undifferentiated, neuroectoderm, meso-
derm, and endoderm germ layer for Cyclin D1-bound protein-coding genes identified by ChIP-seq. Cyclin D1 protein-coding target genes
(740) were associated (677 of 740) with FPKM (fragments per kilobase per million mapped fragments) values and differential expression
analysis of RNA-seq (HUES64 vs. endoderm, HUES64 vs. mesoderm, or HUES64 vs. ectoderm) for all protein-coding genes expressed
in hESCs and the differentiated populations (Supplemental Table S2; Gifford et al. 2013).Z-scores indicate the differential expressionmea-
sured in the number of standard deviations from the average level across all germ layer and hESC conditions. Representative developmen-
tal genes with a significant change in expression are listed for each gene cluster.
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neuroectoderm loci but not on endoderm loci (Fig. 5A).
Thus, Cyclin D1 could be necessary for the deposition of
this positive epigenetic mark. Interestingly, Cyclin D1
has previously been shown to interact with transcription-
al coactivator and histone modifier p300 on the PPARγ-
responsive element of the lipoprotein lipase promoter
during adipocyte formation (Kim et al. 2000; Fu et al.
2005a,b). We therefore performed coimmunoprecipita-
tions (co-IPs) between Cyclin Ds and p300 from the chro-
matin fraction of hESCs, which indicated that these
proteins can also form a complex in stem cells (Fig. 5B).
Protein truncation analyses further showed that these in-
teractions involved the domain of Cyclin D1 spanning
residues 91–179, thereby confirming a direct interaction
(Supplemental Fig. S6A). Finally, ChIP analyses showed
that p300 recruitment to neuroectodermal loci was im-
paired in hESCs knocked down for the expression of Cy-
clin Ds, whereas overexpression of Cyclin D1 increases
the presence of p300 on these loci (Fig. 5C; Supplemental
Fig. S6B–D).
In contrast to H3K4me3, the knockdown of Cyclin Ds
led to the loss of the repressive histone mark H3K27me3
in endoderm loci (Fig. 5A). In agreement with this and
with a previous study (Fu et al. 2005a), we also found
that Cyclin Ds can interact with the transcriptional re-
pressor HDAC1 (Fig. 5B), andCyclinD knockdown causes
Figure 4. Cyclin D1 binds to its developmental target genes in a cell cycle-dependent manner. (A) Representative Cyclin D1-binding re-
gions close to developmental genes spanning 50 kb upstream of and 50 kb downstream from each ChIP-seq peak. Cyclin D1 binding was
identified by ChIP-seq analysis of endogenous Cyclin D1 in hESCs. (B) Cyclin D1 ChIP-qPCR at genomic regions close to selected devel-
opmental loci that were identified as Cyclin D1-binding sites by ChIP-seq. Significant differences calculated by t-test aremarked. (C ) Cy-
clin D1 overexpression induces its neuroectodermal target genes while reducing its endoderm target genes. Gene expression changes of
Cyclin D target genes in Cyclin D1-overexpressing cells, CycD1-K112E-overexpressing cells, and Cyclin D1/Cyclin D2 double-knock-
down cells expressing shRNAs compared with control cells expressing GFP. Significant differences compared with GFP overexpression
and calculated by t-test are marked. (D,E) Cell cycle-dependent binding of Cyclin D1 to neuroectoderm genes (D) and endoderm genes
(E). Cyclin D1 ChIP was performed on Tra-1–60-positive FACS-sorted Fucci hESCs, and then qPCR was performed to detect the genes
denoted. Significant differences compared with G2/M phase and calculated by t-test are marked. All data are shown as mean ± SD. n = 3.
Stem cell differentiation is regulated by Cyclin D
GENES & DEVELOPMENT 427
 Cold Spring Harbor Laboratory Press on April 1, 2018 - Published by genesdev.cshlp.orgDownloaded from 
its loss on endoderm loci (Fig. 5D). We performed sequen-
tial ChIP of Cyclin D1 andHDAC1 or p300, validating the
simultaneous binding of these transcriptional and cell cy-
cle regulators on developmental gene promoters (Fig. 5E,
F), while Cyclin D1 overexpression in hESCs increases
HDAC1 binding to endoderm loci (Supplemental Fig.
S6E,F). Altogether, these results imply that Cyclin Ds
bind the promoters of developmental genes in stem cells,
influencing their epigenetic status by interactingwith epi-
genetic modifiers.
Finally, we validated the functional importance of these
interplays by generating a luciferase reporter system
with regulatory regions bound by Cyclin D1 on its corre-
sponding target loci. We cotransfected these luciferase
Figure 5. Cyclin Ds interact with transcriptional coregulators to control germ layer specification genes. (A) Cyclin D expression pro-
motes the deposition of active histone mark H3K4me3 on neuroectoderm genes and repressive histone mark H3K27me3 on endoderm
genes. ChIP of histone H3K4me3 and H3K27me3 was performed on Tra-1–60-positive Cyclin D double-knockdown hESCs, and then
qPCR was performed to detect genomic regions corresponding to selected key developmental genes. hESCs expressing Scramble shRNA
(Scr/Scr) were used as a control. The dashed line indicates no change with respect to Scr/Scr ChIP. Significant differences compared with
Scr/Scr and calculated by t-test are marked. (B) Cyclin D1–D3 interact with p300 and HDAC1 on chromatin of hESCs. Cyclin Ds were
immunoprecipitated fromchromatin fractions and analyzed for the presence of p300 andHDAC1byWestern blot. (C,D) CyclinD proteins
recruit transcriptional coregulators to loci controlling germ layer specification. ChIP of coactivator p300 and corepressor HDAC1was per-
formed onTra-1–60-positiveCyclinD double-knockdown hESCs, and then qPCRwas performed to detect genomic regions corresponding
to developmental genes regulating neuroectoderm (C ) and endoderm (D) specification. hESCs expressing Scramble shRNA (Scr/Scr) were
used as a control. Significant differences compared with Scr/Scr and calculated by t-test aremarked. (E,F ) Cyclin D is necessary to recruit
p300 to neuroectoderm loci andHDAC1 to endoderm loci in hESCs. Sequential ChIPwas carried out in Scr/Scr andCyclinD1/D3 double-
knockdown cells by first performing a Cyclin D1 ChIP followed by p300 or HDAC1 ChIP on neuroectoderm (E) and endoderm (F ) loci.
Significant differences compared with Scr/Scr and calculated by t-test are marked. (G) Cyclin Ds can induce transcriptional activity of
neuroectoderm genes and repress transcriptional activity of endoderm genes. A luciferase expression construct containing promoter re-
gions of the developmental genes with Cyclin D1-binding sites was transfected together with Cyclin D1–3 and analyzed for luciferase
activity 48 h after transfection. Renilla luciferase was used as an internal control during transfections. Significant differences compared
with GFP overexpression and calculated by t-test are marked. All data are shown as mean ± SD. n = 3.
Pauklin et al.
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constructs into hESCs with Cyclin D1–3 and analyzed
promoter activities after 48 h. These experiments showed
that Cyclin Ds could activate reporters for neuroectoderm
genes (Fig. 5G), indicating the capacity of these cell cycle
regulators to induce transcription. On the other hand, we
observed that overexpression of Cyclin Ds limits their
transcriptional activity of endoderm genes, confirming
that these cell cycle regulators could also act as transcrip-
tional repressors (Fig. 5G).
These data collectively demonstrate that Cyclin Ds
control the expression of regulators of neuroectoderm
and endoderm differentiation in hESCs by recruiting tran-
scriptional coactivators and corepressors onto their pro-
moters regions.
Cyclin D1 binds transcription factors to control
the induction of endoderm and neuroectoderm
genes in stem cells
Cyclin D1 is likely to recruit epigenetic regulators onto
distinct genomic regions by cooperating with sequence-
specific transcription factors. To identify its potential co-
regulators, we performed de novomotif discovery analysis
followed by a comparison of detected motifs against data-
bases using MEME-ChIP (Machanick and Bailey 2011)
on the DNA sequences associated with Cyclin D1-bind-
ing sites. The most significantly overrepresented motifs
found corresponded to SP1, E2Fs, EGR1, Zfp281, FoxP1,
CTCF, and Zfn263 (Fig. 6A; Supplemental Fig. S7A; full
list in Supplemental Table S7). Next, we decided to char-
acterize the functional cooperation between Cyclin D1
and the identified transcription factors in more detail, fo-
cusing on SP1 and E2F1/4/6 as being among the top hits
identified by the transcription factor motif comparison.
Co-IP experiments verified that Cyclin D1 and SP1 could
be found in the same protein complexes on chromatin in
hESCs (Fig. 6B). Transient overexpression of SP1 in hESCs
resulted in the induction of SOX3, OTX1, and PAX2
reporter genes, suggesting that the binding of SP1 on
these neuroectodermal gene promoters could be function-
al. Of note, sequential ChIP with Cyclin D1 and SP1 con-
firmed the interactions between these two proteins on
DNA (Fig. 6D). Finally, Cyclin D1 overexpression did
not alter the presence of SP1 (Supplemental Fig. S7B) on
neuroectodermal promoters, while SP1 binding to neuro-
ectoderm loci did not change significantly during the cell
cycle (Fig. 6E).
Concerning endoderm genes, co-IP (Fig. 6B; Supplemen-
tal Fig. S7D,E) and sequential ChIP (Fig. 6F) experiments
confirmed that Cyclin D1 and E2Fs could be found in
the same protein complex on Wnt3, Sox18, and INHBA
regulatory regions. Transient overexpression of E2F1 was
able to reduce the activity of endoderm reporter genes,
while cotransfection of Cyclin D1 further strengthened
this repressive effect (Fig. 6G), thereby implying that
E2F1 and Cyclin D1 binding could be functional. The in-
crease or decrease in Cyclin D1 expression did not affect
the presence of E2F1 on Wnt3, Sox18, and INHBA pro-
moters (Supplemental Fig. S7C), and E2F1 binding to
DNA was not cell cycle-dependent (Fig. 6H). Therefore,
E2F1 could bind endodermal promoters independently of
cell cycle regulations. These results suggest that E2F1 is
involved in transcriptionally repressive interaction with
Cyclin D1 protein specifically in late G1.
Taken together, these results reveal that the activity of
transcription factors can be cell cycle-regulated through
their interactions with Cyclin D1 (Fig. 7) and that this
regulation establishes the epigenetic modifications neces-
sary for transcriptional initiation of developmental mas-
ter regulators during primary germ layer specification.
Discussion
Here we uncovered that, in addition to their cross-talk
with the signaling pathway Activin/Nodal–Smad2/3, the
mitogenic sensor Cyclin D1 also orchestrates cell fate de-
cisions of stem cells via a complementary mechanism
that involves a direct transcriptional regulation of devel-
opmental master regulators (Fig. 7). These results reveal
the mechanisms by which cell fate decisions are initiated
during the narrow opportunity window of G1 phase when
Cyclin Ds are dynamically expressed. Accordingly, endo-
derm induction occurs in early G1 when the level of Cy-
clin Ds is low, allowing Smad2/3 to bind and activate
endoderm genes. In late G1, Cyclin D1 is induced and
forms a complex with locus-specific transcription factors
to recruit transcriptional coactivators onto neuroecto-
derm genes and corepressors onto endoderm genes. This
model explains the molecular mechanisms allowing cell
cycle regulators to directly control differentiation by
regulating transcription factor activity during cell cycle
progression and provides further support for cell cycle-co-
ordinated cell fate decisions in stem cells.
Importantly, similar cell cycle-dependent transcrip-
tional mechanisms converging on developmental factors
could apply to other cell cycle regulators in pluripotent
cells. For instance, RB genes (pRB, Rbl1, and Rbl2) affect
differentiation in mouse ESCs (mESCs) and hESCs (Con-
klin et al. 2012). Furthermore, the CDK inhibitor p27 co-
operates with Rbl2 to repress Sox2 expression during
differentiation of mESCs (Li et al. 2012) while promoting
the expression of mesodermmarkers brachyury and twist
in hESCs (Menchon et al. 2011). Transcriptional regula-
tion of developmental genes by cell cycle regulators could
therefore be a common mechanism, and a complex cross-
talk is likely to occur between these proteins.
Our results also uncover the mechanisms by which cell
cycle regulators are recruited to specific genomic loca-
tions in hESCs. Indeed, we performed for the first time a
genome-wide survey of Cyclin D1 location on the stem
cell chromatin, and this analysis proved that Cyclin Ds
have the capacity to interact with transcription factors
SP1 and E2F1. Interestingly, SP1 knockout mice have re-
duced embryo size and a diversity of phenotypes that are
lethal before 9.5 d post-coitum (dpc) (Marin et al. 1997).
These observations suggest that SP1 is involved in con-
trolling cell proliferation and tissue differentiation in the
early embryo and thus that the mechanisms described in
our model could be relevant for normal development.
Stem cell differentiation is regulated by Cyclin D
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Figure 6. Cyclin D regulates transcriptional initiation by forming a complex with SP1 and E2F1 on developmental loci. (A) Comparison
of consensus DNA sequence motifs identified in Cyclin D1-binding sites by MEME-ChIP with known DNA motifs using TOMTOM
(Gupta et al. 2007). (B) Cyclin D binds to E2F1/4/6 and SP1 on chromatin of hESCs. Chromatin fractions were isolated from hESCs and
used for immunoprecipitation studies. Coimmunoprecipitated proteins were detected by Western blotting. (C ) A luciferase expression
construct containing promoter regions of neuroectoderm genes with Cyclin D1-binding sites was cotransfected with SP1 or Cyclin D1
and analyzed for luciferase activity 48 h after transfection. Renilla luciferase was used as an internal control during transfections. Signifi-
cant differences comparedwithGFP overexpression and calculated by t-test aremarked. (D) Cyclin D forms a complexwith SP1 on neuro-
ectoderm loci. Sequential ChIP of Cyclin D1 and SP1 in Scrambled (Scr/Scr) and Cyclin D1/D2 double-knockdown cells. Significant
differences compared with Cyclin D1 ChIP/SP1 ChIP in Scrambled (Scr/Scr) cells and calculated by t-test are marked. (E) SP1 binds to
neuroectoderm promoters throughout the cell cycle. Fucci hESCs were sorted into different cell cycle phases and analyzed by SP1
ChIP. (F ) Cyclin D1 forms a complex with E2F1 on endoderm loci Wnt3, INHBA, and Sox18. Sequential ChIP of Cyclin D1 and E2F1
in Scrambled (Scr/Scr) and Cyclin D1/D2 double-knockdown cells. Significant differences compared with Cyclin D1 ChIP/E2F1 ChIP
in Scrambled (Scr/Scr) cells and calculated by t-test aremarked. (G) A luciferase expression construct containing regulatory regions of en-
doderm genes with Cyclin D1-binding sites was transfected together with E2F1 or cotransfected with Cyclin D1 and analyzed for lucif-
erase activity 48 h after transfection. Renilla luciferase was used as an internal control during transfections. Significant differences
compared with GFP overexpression and calculated by t-test are marked. (H) E2F1 binds to endoderm promoters Wnt3, INHBA, and
Sox18 throughout the cell cycle. Fucci hESCs were sorted into different cell cycle phases and analyzed by E2F1 ChIP. All data are shown
as mean ± SD. n = 3.
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The importance of E2F1 in vivo is more complicated to
establish, since E2F genes are known to be functionally re-
dundant during embryonic development (Tsai et al. 2008).
However, pRB and E2F family members can control neu-
ronal and pancreatic development by direct regulation of
genes such as Ngn3 (Kim and Rane 2011; Tsume et al.
2012). Thus, E2F factors could orchestrate stem cell and
progenitor differentiation in a diversity of tissues, under-
lining that cell cycle control of cell fate choice could be
a commonmechanism between a diversity of progenitors.
The absence of Cyclin Ds or CDK4/6 has only modest
effects on early mouse development despite their univer-
sal function in primary and cancer cells. Functional re-
dundancy between cell cycle regulators is frequently
mentioned to explain this relative lack of role in vivo
(Jena et al. 2002; Kozar et al. 2004; Yu and Sicinski 2004;
Ciemerych and Sicinski 2005). Nevertheless, Cyclin Ds
have a tissue-specific expression during gastrulation
(Wianny et al. 1998) that resembles the pattern observed
during differentiation of hESCs in vitro, suggesting that
their role in the mechanisms controlling early cell fate
decisions could be conserved in vivo. Cyclin D activity
also promotes neuroectoderm formation during induced
pluripotent stem cell generation through up-regulating
Pax6 (Chen et al. 2014), and, importantly, Cyclin Dmain-
tains the self-renewal of a broad number of adult stem
cells, including mammary stem and progenitor cells
(Jeselsohn et al. 2010), neuronal stem cells (Roccio et al.
2013), and hematopoietic stem cells (Lange and Calegari
2010). Therefore, the basic mechanisms uncovered by
these studies could also be relevant for adult stem cells
and represent an important step toward understanding
the balance between differentiation and self-renewal dur-
ing organ development and repair.
Materials and methods
Cell culture of hESCs
hESCs (H9 fromWiCell) andmEpiSCs were grown in defined cul-
ture conditions as described previously (Brons et al. 2007). H9
cells were passaged weekly using collagenase IV and maintained
in chemically defined medium (CDM) supplemented with 10 ng/
mL Activin A and 12 ng/mL FGF2.
Differentiation of hESCs
hESCs were differentiated into neuroectoderm, endoderm, and
mesoderm as described previously (Vallier et al. 2009). Briefly,
cells were cultured in CDM supplemented with 10 µM SB-
431542 (Tocris) and 12 ng/mL FGF2 for neuroectoderm; in
CDM+ PVA supplemented with 100 ng/mL Activin A, 20 ng/mL
FGF2, 10 ng/mL BMP4, 10 µM Ly294002 (Promega), and 3 µM
CHIR99021 (Selleck) for mesoderm; and in CDM− PVA sup-
plemented with 100 ng/mL Activin A, 20 ng/mL FGF2,
10 ng/mL BMP4, and 10 µM Ly294002 (Promega) for endoderm.
hESCs were differentiated as described before (Pauklin and
Vallier 2013).
ChIP-seq
ChIP samples were sequenced at the Cambridge Institute Next-
Generation Sequencing service of the University of Cambridge
using Illumina HiSeq, and the raw data have been deposited on
ArrayExpress under accession number E-MTAB-3807. Peak call-
ing analysis (Bailey et al. 2013) was performed using PeakRanger
(Feng et al. 2011), and only the peaks that were reproducible at an
FDRof≤0.01 in two biological replicateswere selected for further
processing.
Extended Materials and Methods with the associated referenc-
es are in the Supplemental Material.
Figure 7. Transcriptional regulation of developmental
genes by Cyclin D proteins during cell cycle progression
of human pluripotent stem cells. Cyclin D binds to SP1
and recruits p300 to neuroectoderm loci for promoting
their transcriptional initiation. In contrast, Cyclin D
binds to E2Fs and recruits HDAC1 to endoderm loci for
blocking their transcriptional initiation.
Stem cell differentiation is regulated by Cyclin D
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